Capsida Biotherapeutics

Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary Adeno-Associated Virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.